The medical journal published two reports on the issue Wednesday on the Internet _ more than two weeks ahead of their planned print publication _ to help inform doctors and patients considering whether to stop using the drugs.
And researchers writing in the New England Journal of Medicine voiced their concerns as well with such drugs as Pfizer's popular Celebrex.
I believe this is a class effect," he said, meaning that the problem also applies to Celebrex and Pfizer's newer, similar drug, Bextra, which remain on the market.
